Interestingly, MMP-2 and MMP-9 can bind to low-density lipoprotein receptor-related protein 1 (LRP1), activate ERK, inhibit the JNK pathway, facilitate tight adhesion of tumor cells to the stroma, and induce tumor cell invasion into blood vessels and lymphatic vessels (41). This evidence concerns the gene MAPK8 and neoplasm.